Physician profile
Lisa K Lee
NPI 1093151169
$2,118.47
in general payments reported to CMS, 2019-2025
22 companies · $81.20 in 2025
The $81.20 reported for 2025 was less than what a typical Clinical Nurse Specialist provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $409 · 2022: $741 · 2023: $677 · 2024: $210 · 2025: $81.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $403.41 | 2021-2024 | Lifevest |
| Irhythm Technologies, INC. | $238.50 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals LP | $211.61 | 2021-2023 | Andexxa |
| Novo Nordisk INC | $164.64 | 2022-2023 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $156.57 | 2022-2024 | Eliquis |
| Amgen INC. | $154.60 | 2021-2023 | Repatha |
| Esperion Therapeutics, INC. | $138.97 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $124.58 | 2022-2023 | Uptravi, Opsumit |
| Pfizer INC. | $115.39 | 2021-2024 | |
| Medtronic, INC. | $69.67 | 2021-2025 | Tyrx, Onyx Frontier |
| Abiomed | $57.49 | 2024 | Impella |
| Janssen Pharmaceuticals, INC | $51.08 | 2021-2023 | Xarelto |
| Alnylam Pharmaceuticals INC. | $39.25 | 2023-2025 | Onpattro |
| Philips North America LLC | $34.42 | 2022 | |
| Kestra Medical Technology Services, INC. | $29.21 | 2025 | Assure Wcd |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $24.93 | 2021 | |
| Cvrx, INC. | $22.00 | 2024 | Barostim Neo System |
| Abbott Laboratories | $20.71 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.23 | 2023 | Jardiance |
| Kiniksa Pharmaceuticals, LTD. | $15.95 | 2023 | Arcalyst |
| Janssen Biotech, INC. | $14.66 | 2023 | Darzalex, Imbruvica |
| Siemens Medical Solutions USA, INC. | $12.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.